Study title:
Muwakkit-S, Geara-F, Nabbout-B, Farah-R-A, Shabb-N-S, Hajjar-T, Khogali-M.
Department of Pediatrics, American University of Beirut Medical Center, Lebanon.
Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
Radiation oncology investigations, {Radiat-Oncol-Investig}, 1999, vol. 7, no. 6, p. 365-73, ISSN: 1065-7541.Muwakkit-S, Geara-F, Nabbout-B, Farah-R-A, Shabb-N-S, Hajjar-T, Khogali-M.
Department of Pediatrics, American University of Beirut Medical Center, Lebanon.
Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
Radiation oncology investigations, {Radiat-Oncol-Investig}, 1999, vol. 7, no. 6, p. 365-73, ISSN: 1065-7541.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: PROCARBAZINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|